Copyright Reports & Markets. All rights reserved.

Global Tocilizumab Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Tocilizumab
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tocilizumab Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Min Purity Less Than 98%
    • 1.3.3 Min Purity 98%-99%
    • 1.3.4 Min Purity More Than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tocilizumab Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medical
  • 1.5 Global Tocilizumab Market Size & Forecast
    • 1.5.1 Global Tocilizumab Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Tocilizumab Sales Quantity (2018-2029)
    • 1.5.3 Global Tocilizumab Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Bio-Rad Laboratories
    • 2.1.1 Bio-Rad Laboratories Details
    • 2.1.2 Bio-Rad Laboratories Major Business
    • 2.1.3 Bio-Rad Laboratories Tocilizumab Product and Services
    • 2.1.4 Bio-Rad Laboratories Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Bio-Rad Laboratories Recent Developments/Updates
  • 2.2 Bio-Techne
    • 2.2.1 Bio-Techne Details
    • 2.2.2 Bio-Techne Major Business
    • 2.2.3 Bio-Techne Tocilizumab Product and Services
    • 2.2.4 Bio-Techne Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Bio-Techne Recent Developments/Updates
  • 2.3 BioVision
    • 2.3.1 BioVision Details
    • 2.3.2 BioVision Major Business
    • 2.3.3 BioVision Tocilizumab Product and Services
    • 2.3.4 BioVision Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 BioVision Recent Developments/Updates
  • 2.4 Selleck Chemicals
    • 2.4.1 Selleck Chemicals Details
    • 2.4.2 Selleck Chemicals Major Business
    • 2.4.3 Selleck Chemicals Tocilizumab Product and Services
    • 2.4.4 Selleck Chemicals Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Selleck Chemicals Recent Developments/Updates
  • 2.5 Biorbyt
    • 2.5.1 Biorbyt Details
    • 2.5.2 Biorbyt Major Business
    • 2.5.3 Biorbyt Tocilizumab Product and Services
    • 2.5.4 Biorbyt Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Biorbyt Recent Developments/Updates
  • 2.6 AbMole
    • 2.6.1 AbMole Details
    • 2.6.2 AbMole Major Business
    • 2.6.3 AbMole Tocilizumab Product and Services
    • 2.6.4 AbMole Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 AbMole Recent Developments/Updates
  • 2.7 Biosynth Carbosynth
    • 2.7.1 Biosynth Carbosynth Details
    • 2.7.2 Biosynth Carbosynth Major Business
    • 2.7.3 Biosynth Carbosynth Tocilizumab Product and Services
    • 2.7.4 Biosynth Carbosynth Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Biosynth Carbosynth Recent Developments/Updates
  • 2.8 SimSon Pharma
    • 2.8.1 SimSon Pharma Details
    • 2.8.2 SimSon Pharma Major Business
    • 2.8.3 SimSon Pharma Tocilizumab Product and Services
    • 2.8.4 SimSon Pharma Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 SimSon Pharma Recent Developments/Updates
  • 2.9 BOC Sciences
    • 2.9.1 BOC Sciences Details
    • 2.9.2 BOC Sciences Major Business
    • 2.9.3 BOC Sciences Tocilizumab Product and Services
    • 2.9.4 BOC Sciences Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 BOC Sciences Recent Developments/Updates
  • 2.10 Clearsynth
    • 2.10.1 Clearsynth Details
    • 2.10.2 Clearsynth Major Business
    • 2.10.3 Clearsynth Tocilizumab Product and Services
    • 2.10.4 Clearsynth Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Clearsynth Recent Developments/Updates
  • 2.11 LifeSpan BioSciences
    • 2.11.1 LifeSpan BioSciences Details
    • 2.11.2 LifeSpan BioSciences Major Business
    • 2.11.3 LifeSpan BioSciences Tocilizumab Product and Services
    • 2.11.4 LifeSpan BioSciences Tocilizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 LifeSpan BioSciences Recent Developments/Updates

3 Competitive Environment: Tocilizumab by Manufacturer

  • 3.1 Global Tocilizumab Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Tocilizumab Revenue by Manufacturer (2018-2023)
  • 3.3 Global Tocilizumab Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Tocilizumab by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Tocilizumab Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Tocilizumab Manufacturer Market Share in 2022
  • 3.5 Tocilizumab Market: Overall Company Footprint Analysis
    • 3.5.1 Tocilizumab Market: Region Footprint
    • 3.5.2 Tocilizumab Market: Company Product Type Footprint
    • 3.5.3 Tocilizumab Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tocilizumab Market Size by Region
    • 4.1.1 Global Tocilizumab Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Tocilizumab Consumption Value by Region (2018-2029)
    • 4.1.3 Global Tocilizumab Average Price by Region (2018-2029)
  • 4.2 North America Tocilizumab Consumption Value (2018-2029)
  • 4.3 Europe Tocilizumab Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Tocilizumab Consumption Value (2018-2029)
  • 4.5 South America Tocilizumab Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Tocilizumab Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Tocilizumab Sales Quantity by Type (2018-2029)
  • 5.2 Global Tocilizumab Consumption Value by Type (2018-2029)
  • 5.3 Global Tocilizumab Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Tocilizumab Sales Quantity by Application (2018-2029)
  • 6.2 Global Tocilizumab Consumption Value by Application (2018-2029)
  • 6.3 Global Tocilizumab Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Tocilizumab Sales Quantity by Type (2018-2029)
  • 7.2 North America Tocilizumab Sales Quantity by Application (2018-2029)
  • 7.3 North America Tocilizumab Market Size by Country
    • 7.3.1 North America Tocilizumab Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Tocilizumab Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Tocilizumab Sales Quantity by Type (2018-2029)
  • 8.2 Europe Tocilizumab Sales Quantity by Application (2018-2029)
  • 8.3 Europe Tocilizumab Market Size by Country
    • 8.3.1 Europe Tocilizumab Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Tocilizumab Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tocilizumab Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Tocilizumab Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Tocilizumab Market Size by Region
    • 9.3.1 Asia-Pacific Tocilizumab Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Tocilizumab Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Tocilizumab Sales Quantity by Type (2018-2029)
  • 10.2 South America Tocilizumab Sales Quantity by Application (2018-2029)
  • 10.3 South America Tocilizumab Market Size by Country
    • 10.3.1 South America Tocilizumab Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Tocilizumab Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tocilizumab Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Tocilizumab Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Tocilizumab Market Size by Country
    • 11.3.1 Middle East & Africa Tocilizumab Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Tocilizumab Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Tocilizumab Market Drivers
  • 12.2 Tocilizumab Market Restraints
  • 12.3 Tocilizumab Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tocilizumab and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tocilizumab
  • 13.3 Tocilizumab Production Process
  • 13.4 Tocilizumab Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tocilizumab Typical Distributors
  • 14.3 Tocilizumab Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
    According to our (Global Info Research) latest study, the global Tocilizumab market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Tocilizumab market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Tocilizumab market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Tocilizumab market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Tocilizumab market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Tocilizumab market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tocilizumab
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tocilizumab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories, Bio-Techne, BioVision, Selleck Chemicals and Biorbyt, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Tocilizumab market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Min Purity Less Than 98%
    Min Purity 98%-99%
    Min Purity More Than 99%
    Market segment by Application
    Research
    Medical
    Major players covered
    Bio-Rad Laboratories
    Bio-Techne
    BioVision
    Selleck Chemicals
    Biorbyt
    AbMole
    Biosynth Carbosynth
    SimSon Pharma
    BOC Sciences
    Clearsynth
    LifeSpan BioSciences
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tocilizumab product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tocilizumab, with price, sales, revenue and global market share of Tocilizumab from 2018 to 2023.
    Chapter 3, the Tocilizumab competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tocilizumab breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tocilizumab market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tocilizumab.
    Chapter 14 and 15, to describe Tocilizumab sales channel, distributors, customers, research findings and conclusion.

    Buy now